// App-Quantinova.ai

TCT-422 : 6 year clinical outcomes after Absorb bioresorbable scaffold implantation in small vessel: The Maasstad Absorb Registry

Researchers

Presenter

  • Valeria Paradies

Principal Investigators

  • Pieter Smits

  • Kees-Jan Royaards

  • Floris Kauer

  • Jochem Wassing

  • Martin van der Ent

  • George Vlachojannis

Medical Centers

  • Unknown, Rotterdam, Netherlands

  • Factoid Team/ CRF, New York, New York, United States

  • Maasstad Hospital, Capelle a/d IJssel, Netherlands

  • Unknown, Alphen aan den Rijn, Netherlands

  • Department of Cardiovascular Surgery, University of Tubingen, Germany, Rotterdam, Netherlands

  • Maasstad Ziekenhuis, Rotterdam, Netherlands

  • Maasstad Ziekenhuis, Rotterdam, Netherlands

Locations

  • United States

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved